Equity research analysts expect Sabra Health Care REIT, Inc. (NASDAQ: SBRA – Get a rating) to report earnings of $0.38 per share for the current quarter, Zacks Investment Research reports. Five analysts provided earnings estimates for Sabra Health Care REIT, with the highest EPS estimate of $0.40 and the lowest estimate of $0.36. Sabra Health Care REIT reported earnings of $0.39 per share in the same quarter last year, indicating a negative 2.6% year-over-year growth rate. The company is due to announce its next earnings report on Monday, January 1.
On average, analysts expect Sabra Health Care REIT to report annual earnings of $1.54 per share for the current year, with EPS estimates ranging from $1.50 to $1.62. For next year, analysts expect the company to post earnings of $1.57 per share, with EPS estimates ranging from $1.51 to $1.66. Zacks’ earnings per share calculations are an average based on a survey of sell-side analysts who track Sabra Health Care REIT.
Sabra Healthcare REIT (NASDAQ: SBRA – Get a rating) last released its quarterly results on Wednesday, May 4. The real estate investment trust reported EPS of $0.18 for the quarter, beating analyst consensus estimates of $0.17 by $0.01. Sabra Health Care REIT posted a negative net margin of 18.28% and a negative return on equity of 3.15%. In the same quarter last year, the company achieved EPS of $0.39.
Several research companies have recently commented on SBRA. Zacks Investment Research upgraded shares of Sabra Health Care REIT from a “sell” rating to a “hold” rating in a Saturday, Feb. 5 research report. Stifel Nicolaus cut his price target on Sabra Health Care REIT shares from $21.00 to $18.00 and set a “buy” rating for the company in a Wednesday, Feb. 23 research report. Mizuho moved shares of Sabra Health Care REIT from a “neutral” rating to a “buy” rating and lowered its target price for the company from $16.00 to $15.00 in a Wednesday research note May 25. Barclays cut shares of Sabra Health Care REIT from an “overweight” rating to an “equal weight” rating and lowered its price target for the company from $16.00 to $14.00 in a research note from the Monday April 18. Finally, Credit Suisse Group raised its price target on shares of Sabra Health Care REIT from $14.00 to $15.00 and gave the company a “neutral” rating in a Monday, April 4 research note. . Seven equity research analysts gave the stock a hold rating and five gave the stock a buy rating. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $15.95.
SBRA action opened at $13.54 on Friday. Sabra Health Care REIT has a 12-month low of $11.44 and a 12-month high of $19.01. The company has a quick ratio of 3.60, a current ratio of 3.60 and a leverage ratio of 0.70. The company has a market capitalization of $3.13 billion, a price-earnings ratio of -27.63 and a beta of 1.42. The company’s fifty-day simple moving average is $13.27 and its 200-day simple moving average is $13.45.
The company also recently declared a quarterly dividend, which was paid on Tuesday, May 31. Investors of record on Monday, May 16 received a dividend of $0.30. This represents an annualized dividend of $1.20 and a yield of 8.86%. The ex-dividend date was Friday, May 13. Sabra Health Care REIT’s dividend payout ratio is currently -244.89%.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Voya Investment Management LLC raised its position in shares of Sabra Health Care REIT by 0.4% during the third quarter. Voya Investment Management LLC now owns 187,382 shares of the real estate investment trust worth $2,758,000 after purchasing an additional 734 shares in the last quarter. US Bancorp DE increased its equity stake in Sabra Health Care REIT by 17.7% during the third quarter. US Bancorp DE now owns 5,533 shares of the real estate investment trust worth $81,000 after acquiring an additional 831 shares during the period. The Alaska State Department of Revenue increased its position in Sabra Health Care REIT shares by 0.6% during the fourth quarter. The Alaska State Department of Revenue now owns 149,160 shares of the real estate investment trust worth $2,019,000 after buying 897 additional shares in the last quarter. Cetera Investment Advisers increased its position in Sabra Health Care REIT by 1.2% in Q1. Cetera Investment Advisers now owns 80,608 shares of the real estate investment trust worth $1,200,000 after acquiring 919 additional shares in the last quarter. Finally, Xponance Inc. increased its position in Sabra Health Care REIT by 2.9% in the 4th quarter. Xponance Inc. now owns 34,248 shares of the real estate investment trust worth $464,000 after acquiring 957 additional shares in the last quarter. Hedge funds and other institutional investors own 91.61% of the company’s shares.
About Sabra Health Care REIT (Get a rating)
As of September 30, 2020, Sabra’s investment portfolio comprised 425 properties held for investment (composed of (i) 287 skilled nursing/transitional care facilities, (ii) 64 retirement homes (Senior Housing – Leased), (iii) 47 Senior Residences operated by third-party property managers under property management contracts (Senior Housing – Managed) and (iv) 27 Specialized Hospitals and Other Establishments), an asset held for the sale, one investment in direct leasing, 19 investments in loans receivable (including (i) one mortgage loan, (ii) one construction loan and (iii) 17 other loans), six investments in preferred shares and one investment in an unconsolidated joint venture that owns 158 seniors’ residences – managed communities.
For more information on Zacks Investment Research’s research offerings, visit Zacks.com
Get news and reviews for Sabra Health Care REIT Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Sabra Health Care REIT and related companies with MarketBeat.com’s free daily email newsletter.